Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
DNA Copy Number Variations
Urinary Bladder Neoplasms
High-grade bladder cancer possesses substantial genomic heterogeneity. The majority of tumors harbor potentially tractable genomic alterations that may predict for response to target-selective agents. Given the genomic diversity of bladder cancers, optimal development of target-specific agents will require pretreatment genomic characterization.